The effectiveness and safety of ledipasvir plus sofosbuvir in adolescents with chronic hepatitis C virus genotype 4 infection: A real-world experience
Alimentary Pharmacology and Therapeutics Jan 24, 2018
El-Khayat HR, et al. - The effectiveness and safety of ledipasvir plus sofosbuvir were examined in chronic hepatitis C virus adolescent patients with genotype 4 in the real world. Ledipasvir plus sofosbuvir regimen was well tolerated and effective. In treating adolescent patients with chronic hepatitis C genotype 4, this treatment could be used safely.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
